R&D to Revenue
73.34%
Fiscal year · Period ending:

BNTX R&D to Revenue
What is r&d to revenue?
R&D spending as percentage of revenue.
BNTX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.
| Period ending | R&D to Revenue | Change |
|---|---|---|
| 73.344% | −8.59 pts | |
| 81.9381% | +35.25 pts | |
| 46.6902% | +38.25 pts | |
| 8.4394% | +3.42 pts | |
| 5.0212% | −128.71 pts | |
| 133.7333% | −74.82 pts | |
| 208.5534% | +96.43 pts | |
| 112.1223% | −26.67 pts | |
| 138.7967% | +138.80 pts | |
| 0% | — |
Frequently asked questions: BNTX r&d to revenue
What is BioNTech SE (BNTX)'s current r&d to revenue?
BioNTech SE (BNTX)'s latest reported r&d to revenue (Fiscal year) is 73.34% as of Dec 31, 2025. R&D spending as percentage of revenue.
How much historical r&d to revenue data is available for BNTX?
Stock Alarm Pro provides 10 dated annual fiscal periods observations for BioNTech SE (BNTX)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare BNTX's r&d to revenue to peers or set an alert?
You can open BNTX's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on BNTX delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare BNTX and MRNA side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance